US Stocks
/
Theriva Biologics, Inc. Share Price
Theriva Biologics, Inc. Share Price

Theriva Biologics, Inc. Share Price

AMEX: TOVX | Micro Cap
$0.19
+$0.00 (0.05%) Last updated on 28 Oct, 2026 | 22:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Theriva Biologics, Inc. Stock Performance

Open
$0.18
Prev. Close
$0.19
Circuit Range
N/A
Day Range
$0.18 - $0.19
Year Range
$0.17 - $0.49
Volume
2,700
Average Traded
$0.19

Theriva Biologics, Inc. Share Price Today

As of 29 October 2026, Theriva Biologics, Inc.'s share price is $0.19. The stock opened at $0.18, compared to its previous close of $0.19. During today's trading session, Theriva Biologics, Inc.'s share price traded between $0.18 and $0.19, with an average price of $0.19. Over the past 52 weeks, the stock has recorded a high of $0.49 and a low of $0.17. In terms of performance, Theriva Biologics, Inc.'s share price has declined by 46.65% over the last six months and is down 39.42% on a year-on-year basis.

Theriva Biologics, Inc. Share Price Chart

$0.18$0.19
L
Show Current Price
H

Theriva Biologics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.28M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.29
Revenue (TTM)
$0.00
Return On Equity (TTM)
-107.72%
Profit Margin
N/A
Debt to Equity
0.14
Quarterly Earnings Growth YoY
26.15%

Theriva Biologics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.30$0.00
Net Profit-$4.36-$3.51-$2.04-$3.22
Net Profit MarginN/AN/A-680.00%N/A
Income ChangeN/A19.50%41.88%-57.84%

Theriva Biologics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$20.03-$18.35-$25.65-$25.25
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A8.39%-39.78%1.56%

About Theriva Biologics, Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Theriva Biologics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.22
$0.19
-18.70%
Sep 2026
$0.24
$0.23
-9.45%
Aug 2026
$0.22
$0.25
+20.38%
Jul 2026
$0.25
$0.21
-16.60%
Jun 2026
$0.28
$0.25
-10.92%
May 2026
$0.36
$0.28
-19.32%
Apr 2026
$0.20
$0.35
+78.68%
Mar 2026
$0.19
$0.20
-1.01%
Feb 2026
$0.18
$0.20
+11.80%
Jan 2026
$0.20
$0.18
-13.59%
Dec 2025
$0.26
$0.21
-24.26%
Nov 2025
$0.31
$0.27
-12.26%

TOVX Share Price FAQs

What is Theriva Biologics, Inc. share price today?

chevron-up
Theriva Biologics, Inc. share price today is $0.19 as on October 28, 2026 at 10:29 pm IST.

What is the 52 week high and 52 week low of Theriva Biologics, Inc. stock?

chevron-up
The 52 week high of Theriva Biologics, Inc. stock is $0.49, while the 52 week low is $0.17 as of 28 Oct '26.

What is TOVX's market capitalisation today?

chevron-up
TOVX market capitalisation is $2.28M as of October 29, 2026, at 4:56 am IST.

What is TOVX's net income for the last quarter?

chevron-up
TOVX's net income for the last quarter is -3.22B USD.

What is the 5 year returns of TOVX?

chevron-up
The 5 year returns of TOVX is -99.82% as on 28 Oct '26.

What is the high & low stock price of TOVX today?

chevron-up
TOVX stock price hit a high of $0.19 and low of $0.18 as of 28 Oct '26.

Can I buy TOVX shares in India?

chevron-up
Yes. You can buy TOVX in India by opening an international trading account.